BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37851900)

  • 1. Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
    Teierle SM; Huang Y; Kittai AS; Bhat SA; Grever M; Rogers KA; Zhao W; Jones D; Byrd JC; Avenarius MR; Heerema NA; Woyach JA; Miller CR
    Blood Adv; 2023 Dec; 7(23):7239-7242. PubMed ID: 37851900
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia.
    Martel V; Guerci A; Humbert JC; Gregoire MJ; Chery M; Lederlin P; Jonveaux P
    Br J Haematol; 1997 Nov; 99(2):320-4. PubMed ID: 9375748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
    Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
    Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiclonal monoallelic 13q14 interstitial deletion in chronic lymphocytic leukemia.
    Hruba M; Subrt I
    Leuk Lymphoma; 2013 Feb; 54(2):413-6. PubMed ID: 22697045
    [No Abstract]   [Full Text] [Related]  

  • 6. Independent clones of trisomy 12 and retinoblastoma gene deletion in Japanese B cell chronic lymphocytic leukemia, detected by fluorescence in situ hybridization.
    Arif M; Tanaka K; Asou H; Ohno R; Kamada N
    Leukemia; 1995 Nov; 9(11):1822-7. PubMed ID: 7475269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of fluorescence in situ hybridization value in detection of chronic lymphocytic leukemia].
    Wu W; Gu J; Ma L; Wang H; Ni J; Ji W; Shen LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1095-8. PubMed ID: 23114126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of p53 gene deletion in Xinjiang patients with chronic lymphocytic leukemia by fluorescence in situ hybridization and its clinical significance].
    Maimaitili Y; Guzailinuer W; Wang X; Liu H; Li Y; Xiao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):499-503. PubMed ID: 25119920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization.
    Amiel A; Mulchanov I; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Jul; 112(1):53-6. PubMed ID: 10432937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.
    Lai YY; Huang XJ
    Chin Med J (Engl); 2011 Aug; 124(16):2417-22. PubMed ID: 21933580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
    Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
    Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S
    Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics.
    Amiel A; Arbov L; Manor Y; Fejgin M; Elis A; Gaber E; Lishner M
    Cancer Genet Cytogenet; 1997 Sep; 97(2):97-100. PubMed ID: 9283589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
    Avenarius MR; Huang Y; Hyak J; Byrd JC; Bhat SA; Grever M; Kittai AS; Rogers KA; Jones D; Zhao W; Heerema NA; Abruzzo LV; Woyach J; Miller CR
    Hematol Oncol; 2023 Oct; 41(4):771-775. PubMed ID: 37010242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
    Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Xiao B; Chen LJ; Wu YF; Sheng RL; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosomal aberrations in chronic lymphocytic leukemia by interphase fluorescence in situ hybridization and their association with clinical features].
    Li WJ; Guo L; Hou M; Sun JZ; Shao LL; Wang SK; Ma DX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):494-8. PubMed ID: 20416197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
    Van Dyke DL; Werner L; Rassenti LZ; Neuberg D; Ghia E; Heerema NA; Dal Cin P; Dell Aquila M; Sreekantaiah C; Greaves AW; Kipps TJ; Kay NE
    Br J Haematol; 2016 Apr; 173(1):105-13. PubMed ID: 26848054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
    Wang H; Xu H; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of RB1 Deletions in Interphase and Metaphase by Molecular Cytogenetics Exemplified in Chronic Lymphatic Leukemia.
    Liehr T
    Methods Mol Biol; 2018; 1726():1-6. PubMed ID: 29468538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.